Role of RONS and eIFs in Cancer Progression
- PMID: 34285764
- PMCID: PMC8275427
- DOI: 10.1155/2021/5522054
Role of RONS and eIFs in Cancer Progression
Abstract
Various research works have piled up conflicting evidence questioning the effect of oxidative stress in cancer. Reactive oxygen and nitrogen species (RONS) are the reactive radicals and nonradical derivatives of oxygen and nitrogen. RONS can act as a double-edged weapon. On the one hand, RONS can promote cancer initiation through activating certain signal transduction pathways that direct proliferation, survival, and stress resistance. On the other hand, they can mitigate cancer progression via their resultant oxidative stress that causes many cancer cells to die, as some recent studies have proposed that high RONS levels can limit the survival of cancer cells during certain phases of cancer development. Similarly, eukaryotic translation initiation factors are key players in the process of cellular transformation and tumorigenesis. Dysregulation of such translation initiation factors in the form of overexpression, downregulation, or phosphorylation is associated with cancer cell's altering capability of survival, metastasis, and angiogenesis. Nonetheless, eIFs can affect tumor age-related features. Data shows that alternating the eukaryotic translation initiation apparatus can impact many downstream cellular signaling pathways that directly affect cancer development. Hence, researchers have been conducting various experiments towards a new trajectory to find novel therapeutic molecular targets to improve the efficacy of anticancer drugs as well as reduce their side effects, with a special focus on oxidative stress and initiation of translation to harness their effect in cancer development. An increasing body of scientific evidence recently links oxidative stress and translation initiation factors to cancer-related signaling pathways. Therefore, in this review, we present and summarize the recent findings in this field linking certain signaling pathways related to tumorigeneses such as MAPK and PI3K, with either RONS or eIFs.
Copyright © 2021 Yasmeen Ahmed Salaheldin et al.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures


Similar articles
-
Reactive Oxygen and Nitrogen Species-Induced Protein Modifications: Implication in Carcinogenesis and Anticancer Therapy.Cancer Res. 2018 Nov 1;78(21):6040-6047. doi: 10.1158/0008-5472.CAN-18-0980. Epub 2018 Oct 16. Cancer Res. 2018. PMID: 30327380 Review.
-
Dual Character of Reactive Oxygen, Nitrogen, and Halogen Species: Endogenous Sources, Interconversions and Neutralization.Biochemistry (Mosc). 2020 Jan;85(Suppl 1):S56-S78. doi: 10.1134/S0006297920140047. Biochemistry (Mosc). 2020. PMID: 32087054 Review.
-
The effect of reactive oxygen and nitrogen species on the structure of cytoglobin: A potential tumor suppressor.Redox Biol. 2018 Oct;19:1-10. doi: 10.1016/j.redox.2018.07.019. Epub 2018 Jul 24. Redox Biol. 2018. PMID: 30081385 Free PMC article.
-
Biological Activities of Reactive Oxygen and Nitrogen Species: Oxidative Stress versus Signal Transduction.Biomolecules. 2015 Apr 15;5(2):472-84. doi: 10.3390/biom5020472. Biomolecules. 2015. PMID: 25884116 Free PMC article. Review.
-
AMPK signaling in skeletal muscle during exercise: Role of reactive oxygen and nitrogen species.Free Radic Biol Med. 2016 Sep;98:68-77. doi: 10.1016/j.freeradbiomed.2016.01.012. Epub 2016 Jan 19. Free Radic Biol Med. 2016. PMID: 26804254 Review.
Cited by
-
Anticancer Effects of Plasma-Treated Water Solutions from Clinically Approved Infusion Liquids Supplemented with Organic Molecules.ACS Omega. 2023 Sep 1;8(37):33723-33736. doi: 10.1021/acsomega.3c04061. eCollection 2023 Sep 19. ACS Omega. 2023. PMID: 37744835 Free PMC article.
-
Nitroproteomics is instrumental for stratification and targeted treatments of astrocytoma patients: expert recommendations for advanced 3PM approach with improved individual outcomes.EPMA J. 2023 Dec 6;14(4):673-696. doi: 10.1007/s13167-023-00348-y. eCollection 2023 Dec. EPMA J. 2023. PMID: 38094577 Free PMC article. Review.
-
eIF6: a promising therapeutic target for gastric carcinoma via PI3K/AKT pathway modulation.World J Surg Oncol. 2025 Apr 1;23(1):113. doi: 10.1186/s12957-025-03746-w. World J Surg Oncol. 2025. PMID: 40170052 Free PMC article.
-
Pretreatment with Liposome-Encapsulated Shrimp Shell Extract Attenuated Neuronal Damage and Death in Aβ1-42-Induced Memory Deficits in Rats.Neurochem Res. 2024 May;49(5):1166-1187. doi: 10.1007/s11064-024-04103-1. Epub 2024 Feb 7. Neurochem Res. 2024. PMID: 38326524
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical